Protalix BioTherapeutics (PLX) EPS (Basic) (QoQ) (2010 - 2026)
Protalix BioTherapeutics (PLX) EPS (Basic) (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.75 Bn | 130.90 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.96 Bn | 77.96 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.98 Bn | 59.80 Bn | 1.37 Bn |
| 4 | Moderna | 56.33 Bn | 51.19 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.56 Bn | 28.25 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.74 Bn | 9.35 Bn | 668.28 Mn |
| 8 | Insmed | 27.47 Bn | 26.31 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.32 Bn | 26.49 Bn | - |
| 10 | Protalix BioTherapeutics | 189.57 Mn | 148.91 Mn | 12.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -79.38% |
| Mar 31, 2026 | 604.69% |
| Dec 31, 2025 | -249.86% |
| Sep 30, 2025 | 506.38% |
| Jun 30, 2025 | 110.63% |
| Mar 31, 2025 | -131.71% |
| Dec 31, 2024 | 215.61% |
| Sep 30, 2024 | 257.09% |
| Jun 30, 2024 | 52.23% |
| Mar 31, 2024 | 78.89% |
| Dec 31, 2023 | -1,063.37% |
| Sep 30, 2023 | -110.62% |
| Jun 30, 2023 | 543.09% |
| Mar 31, 2023 | 17.75% |
| Dec 31, 2022 | 8.10% |
| Sep 30, 2022 | 36.06% |
| Jun 30, 2022 | -126.02% |
| Mar 31, 2022 | 66.72% |
| Dec 31, 2021 | -58.93% |
| Sep 30, 2021 | 62.32% |